Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASTRO Annual Meeting
H&N 3 – Novel Approaches to the Treatment of Oropharynx Cancer
Room 11 A/B
11AM
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Oral
Yvonne Pham, MD
Impact of Smoking on Outcomes in HPV+ Oropharynx Cancer: It′s More than Pack-Years
Biology 7 – Sensitizers, Response, and Models
Room 2
1:30PM
Oral
Brian Yard, MD
Systematic Annotation of Genetic Variants That Confer Resistance to Radiation: A Pan-Cancer Encyclopedia
Head and Neck ePoster Discussion
Hall A-B1, Ground Level
1:30PM
ePoster
Matthew Ward, MD
A Nomogram to Predict Severe Late Toxicity after Definitive Reirradiation for Squamous Carcinoma of the Head and Neck
CNS 2 – Brain and Spine Metastases and Treatment Related Toxicity
Room 2
3:15PM
Oral
Aditya Juloori, MD
Use of Concurrent TKIs with SRS is Associated with an Increased Rate of Radiation Necrosis among Patients with Renal Cell Carcinoma Brain Metastasis
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust